TOPLINE: A recent study identified three clinically distinct vitiligo profiles on the basis of Vitiligo Patient Priority Outcomes (ViPPO) responses from real-world patient data. Classes with more severe emotional and social functioning impacts had more severe disease per physician assessment, visible areas of lesion involvement, and work productivity and quality-of-life (QoL) impairment. METHODOLOGY: Researchers collected … Read more
A new study by Kang et al. has uncovered a surprising potential benefit of PCSK9 inhibitors—drugs typically prescribed to lower cholesterol. Through Mendelian randomization (MR), researchers found that people with genetic variants mimicking the effects of PCSK9-inhibiting drugs had a lower risk of developing vitiligo. This unexpected link offers fresh insight into vitiligo’s underlying biology … Read more
A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new Northwestern University pre-clinical study in mice. The findings could offer hope to millions affected by the autoimmune disease, which causes visible patches of skin discoloration and carries profound emotional and physical consequences. The results in … Read more